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Abstract: FKBP5 encodes FK506-binding protein 5, a glucocorticoid receptor (GR)-binding protein
implicated in various psychiatric disorders and alcohol withdrawal severity. The purpose of this
study is to characterize alcohol preference and related phenotypes in Fkbp5 knockout (KO) mice
and to examine the role of FKBP5 in human alcohol consumption. The following experiments were
performed to characterize Fkpb5 KO mice. (1) Fkbp5 KO and wild-type (WT) EtOH consumption
was tested using a two-bottle choice paradigm; (2) The EtOH elimination rate was measured after
intraperitoneal (IP) injection of 2.0 g/kg EtOH; (3) Blood alcohol concentration (BAC) was measured
after 3 h limited access of alcohol; (4) Brain region expression of Fkbp5 was identified using LacZ
staining; (5) Baseline corticosterone (CORT) was assessed. Additionally, two SNPs, rs1360780 (C/T)
and rs3800373 (T/G), were selected to study the association of FKBP5 with alcohol consumption
in humans. Participants were college students (n = 1162) from 21–26 years of age with Chinese,
Korean or Caucasian ethnicity. The results, compared to WT mice, for KO mice exhibited an increase
in alcohol consumption that was not due to differences in taste sensitivity or alcohol metabolism.
Higher BAC was found in KO mice after 3 h of EtOH access. Fkbp5 was highly expressed in brain
regions involved in the regulation of the stress response, such as the hippocampus, amygdala, dorsal
raphe and locus coeruleus. Both genotypes exhibited similar basal levels of plasma corticosterone
(CORT). Finally, single nucleotide polymorphisms (SNPs) in FKBP5 were found to be associated with
alcohol drinking in humans. These results suggest that the association between FKBP5 and alcohol
consumption is conserved in both mice and humans.
Int. J. Mol. Sci. 2016, 17, 1271; doi:10.3390/ijms17081271 www.mdpi.com/journal/ijms
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1. Introduction
Alcohol use disorder displays a high level of comorbidity with several psychiatric disorders [1,2].
Dysregulation of a primary component of the stress response, the hypothalamic-pituitary-adrenal
(HPA) axis, has been implicated in the pathophysiology of these psychiatric disorders [3–6] and
mediates the transition from episodic drug and alcohol use to dependence [7–10]. Glucocorticoids,
glucocorticoid receptor (GR) and its binding proteins (e.g., Fkbp5, FK506 binding protein 5, also known
as FKBP51) are critical HPA axis regulatory elements.
Diverse lines of research suggest a correlation between glucocorticoid levels and alcohol
consumption. For instance, increases in HPA axis responsivity in young primates predicted higher
levels of future alcohol consumption [11]. Alcohol consumption and withdrawal have both been
shown to increase circulating glucocorticoids and to decrease GR availability [12], and the release
of high levels of glucocorticoid peptides has been shown to sensitize the reward pathways in the
brain [13–15]. Other research indicates that the GR plays an important role in the determination
of alcohol abuse. Polymorphisms in the GR are associated with the onset of alcohol abuse in
adolescents [6]; GR-mediated plasticity increased voluntary alcohol consumption in rats [16]; and a
GR antagonist reduced alcohol intake in rats [17]. Thus, the GR is a worthy target of research aimed at
identifying novel treatment strategies for alcohol use disorder.
GR binding proteins are critical for GR function and GR-regulated behavior. However, limited
research has been done to investigate the role of GR binding proteins in behaviors related to alcohol
use disorder. FKBP5 is a GR binding protein that acts as a co-chaperone of heat shock protein 90 and is
involved in regulating GR activity, nuclear translocation and transcriptional regulation of GR-targeted
genes [18–20]. Functionally, FKBP5 is a potent inhibitor of GR activation and a determinant of HPA axis
regulation [21]. As replicated in other studies, both Fkbp5 knockout (KO) mice and FKBP5 knockdown
neuronal cell cultures exhibit elevated GR nuclear translocation [22,23].
High expression of Fkbp5 has been observed in the brain, especially, hippocampus [24], which is
consistent with its function in the stress response. Increased hippocampal expression of Fkbp5 mRNA,
as well as increased plasma corticosterone (CORT) levels and adrenal gland weight were observed
after chronic social defeat in mice [25]. When compared to WT mice prior to chronic social defeat,
Fkbp5-deficient mice exhibited lower basal CORT and lower adrenal weights [26].
Fkbp5 gene expression is not only induced by stress [27], but also by alcohol [28,29] and drug
administration [30]. In addition, glucocorticoid treatment increased Fkbp5 expression in peripheral
tissue [31] and the brain [32]. Consistent with the effects of alcohol on Fkbp5 gene expression in the CNS
following acute alcohol injection, these findings suggest that increases in Fkbp5 expression following
steroid receptor activation reduce GR sensitivity and, in turn, modulate GR-related behavior [28,33].
FKBP5 SNPs and gene expression levels are associated with the onset of posttraumatic stress
disorder (PTSD) and anxiety disorder in humans [20,34]. Particularly, two SNPs, rs1360780 (C/T)
and rs3800373 (T/G) are often used for association studies. In humans, alcohol use disorder is often
comorbid with anxiety and other psychiatric disorders [2,35]. In rodents, anxiety is correlated with
alcohol preference in various models of alcohol use disorder [36,37]. Genetic variations of FKBP5 are
associated with an increased risk for depression [38,39], PTSD [40] and bipolar disorder [41] and are also
associated with a greater risk for comorbid alcohol dependence and PTSD onset [42]. Moreover, FKBP5
SNPs are associated with the degree of cortisol response [20,21], response to antidepressants [38–40],
heroin addiction [43] and alcohol withdrawal severity [5]. For example, heterozygous and homozygous
carriers of the rs3800373 (T/G and G/G) or rs1360780 (C/T and T/T) variants are more likely to respond
to antidepressant drugs [44]. Some findings suggest that the G allele of rs3800373 and the T allele
of rs1360780 (minor alleles) may represent protective alleles for PTSD with a history of childhood
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abuse, while the major alleles, T allele of rs3800373 and C allele of rs1360780, represent risk alleles for
comorbid alcohol dependence and PTSD onset [42]. However, correlations between the risk allele of
FKBP5 and onset of PTSD have been inconsistent, and no direct research has investigated FKBP5 and
its role in alcohol consumption.
In the current study, we utilize the Fkbp5 KO mouse model to address the functional relevance of
Fkbp5 in alcohol consumption and to map Fkbp5 gene expression in brain. Furthermore, we extend the
mouse findings by determining associations between FKBP5 SNPs and alcohol drinking behaviors in
humans, an effort critical for future translational research. Taken together, our findings are the first to
demonstrate a role for Fkbp5 in the regulation of alcohol drinking in both mice and humans.
2. Results
2.1. Alcohol Consumption Is Increased in Fkbp5´/´ Mice
Studies suggest that alcohol consumption is directly affected by circulating corticoid and GR
availability [12] and that FKBP5 plays a role in GR activation and HPA axis regulation [21]. In order to
ascertain whether alcohol consumption was affected by Fkbp5 gene knockout, a series of drinking tests
were performed in both male and female adult mice. In the established alcohol drinking test protocol,
two indices were calculated including alcohol consumption (g EtOH/kg body weight/day) and alcohol
preference (percentage of EtOH/total fluid, v/v). A significant genotypic effect was observed on
male alcohol consumption using repeated measures two-way ANOVA with F (1,47) = 9.27, p = 0.0038.
Sidak’s multiple comparisons post hoc test revealed significant differences at 9% (p = 0.0226), 12%
(p = 0.0081) and 15% (p = 0.0002) (Figure 1A). However, while repeated measures two-way ANOVA
revealed significant differences due to ethanol concentration (p < 0.0001), no genotypic effects were
observed in female alcohol consumption or in ethanol preference of either sex (Figure 1B–D). During
the drinking tests, the body weight was measured twice per week. No significant changes in body
weight were detected within genotype, regardless of sex. When different concentrations of alcohol
were presented with water, the total fluid intake (volume of alcohol plus water) of KO mice was lower
than WT in general, but only in males, this difference found to be significant via repeated measures
two-way ANOVA with F (1,47) = 11.07, p = 0.0017. Sidak’s multiple comparisons post hoc test revealed
significant differences at 6% (p = 0.0043), 9% (p = 0.0495) and 15% (p = 0.0032) (Figure 1E,F). Taken
together, the current results suggest that deficiency of Fkbp5 can enhance EtOH intake, at least in males.
To exclude the possibility that taste sensitivity may have been influenced by Fkbp5 KO, animals
were tested for quinine consumption (Figure 1G), but no significant difference was observed between
KO and WT mice of either sex. Finally, we determined whether the observed differences in alcohol
consumption might be due to differences in the rate of alcohol metabolism between genotypes.
An ethanol dose of 2.0 g/kg body weight was injected intraperitoneally (IP), and the EtOH elimination
rate was assessed. Regardless of sex, no significant difference in alcohol elimination rate was observed
between Fkbp5 KO (1.2 ˘ 0.13 mg% EtOH per min) and WT mice (0.9 ˘ 0.23 mg% EtOH per min)
(Figure 1H).
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Figure 1. EtOH consumption and preference, quinine consumption and EtOH metabolism in Fkbp5 
KO and WT mice. A significant increase in alcohol consumption (A) in male mice was observed in the 
KO mice at 9%, 12% and 15% EtOH concentrations when compared to WT mice. No significant 
increases in alcohol consumption (C) in female mice or preference (B,D) in either sex were observed. 
Lower total fluid consumption was observed (E) in male mice, but not (F) in female mice during the 
EtOH consumption test. KO and WT mice did not differ in quinine consumption (G). No differences 
in alcohol metabolism were found between KO and WT mice (H). *, p < 0.05, **, p < 0.01, ***, p < 0.001. 
  
Figure 1. EtOH consumption and preference, quinine consumption and EtOH metabolism in Fkbp5
KO and WT mice. A significant increase in alcohol consumption (A) in male mice was observed in
the KO mice at 9%, 12% and 15% EtOH concentrations when compared to WT mice. No significant
increases in alcohol consumption (C) in female mice or preference (B,D) in either sex were observed.
Lower total fluid consumption was observed (E) in male mice, but not (F) in female mice during the
EtOH consumption test. KO and WT mice did not differ in quinine consumption (G). No differences in
alcohol metabolism were found between KO and WT mice (H). *, p < 0.05, **, p < 0.01, ***, p < 0.001.
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2.2. Blood Alcohol Concentration Is Higher in KO than WT Mice
Blood alcohol concentration (BAC) was measured after 3 h of limited access to 15% EtOH. Fkbp5
KO mice consumed more alcohol than WT mice (mean = 2.24 g EtOH/kg body weight for KO vs.
0.94 g/kg for WT), resulting in higher BACs for KO mice compared to WT mice (mean = 53 ˘ 1.3 mg%
EtOH in KO vs. 25.9 ˘ 1.92 mg% EtOH in WT).
2.3. The Fkbp5 Gene Is Highly Expressed in Brain Regions Important for the Stress Response
FKBP5 has been found to have reduced expression in individuals with PTSD [45]. Fkbp5-deficient
mice were generated using a gene-trapping approach [46] in which the LacZ reporter gene was
inserted. Previous studies have also shown that the murine Fkbp5 gene is expressed in various tissues,
including brain and peripheral tissue. We therefore charted the Fkbp5 gene expression pattern in
KO mice by staining for the LacZ gene product. In the brains of one-month-old Fkbp5 KO mice,
LacZ staining revealed Fkbp5 expression in the hippocampus, striatum, dorsal raphe (DR) and locus
coeruleus (LC) (Figure 2B). In four-month-old Fkbp5 KO mice, LacZ staining was observed in the
hippocampus and additional brain regions, such as amygdala (Figure 2D). Whole brain LacZ staining
followed by sectioning and eosin red staining in four-month-old KO mice revealed that Fkpb5 was
highly expressed in the lateral septum, which includes lateral septal nuclei dorsal (LSD), ventral
(LSV) and intermediate (LSI) (Figure 2F); bed nucleus of the striatum terminalis (BST) (Figure 2F);
and hippocampus (Figure 2H,J). In the four-month-old hippocampus, LacZ staining suggested that
Fkbp5 is highly expressed in CA1, CA2, CA3 and the dentate gyrus (DG) (Figure 2D,H,J). Consistent
with the absence of the LacZ reporter gene, WT control mice did not exhibit any LacZ staining
(Figure 2A,C,E,G,I).
Int. J. Mol. Sci. 2016, 17, 1271 5 of 17 
 
2.2. Blood Alcohol Concentration Is Higher in KO than T ice 
Blood alcohol concentration (BAC) was measured after 3 h of limited access to 15% EtOH. Fkbp5 
KO mice consumed more alcohol than T mice (mean = 2.24 g EtOH/kg body weight for KO vs.  
0. 94 g/kg for T), resulting in higher BACs for KO mice compared to T mice (mean = 53 ± 1.3 mg% 
EtOH in KO vs. 25.9 ± 1.92 mg% EtOH in T). 
2.3. The Fkbp5 Gene Is Highly Expressed in Brain Regions Important for the Stress Response 
FKBP5 has been found to have reduced expression in individuals with PTSD [45]. Fkbp5-deficient 
mice were generated using a gene-trapping approach [46] in which the LacZ reporter gene was 
inserted. Previous studies have also shown that the murine Fkbp5 gene is expressed in various tissues, 
including brain and peripheral tissue. We therefore charted the Fkbp5 gene expression pattern in KO 
mice by staining for the LacZ gene product. In the brains of one-month-old Fkbp5 KO mice, LacZ 
staining revealed Fkbp5 expression in the hippocampus, striatum, dorsal raphe (DR) and locus 
coeruleus (LC) (Figure 2B). In four-month-old Fkbp5 KO mice, LacZ staining was observed in the 
hippocampus and additional brain regions, such as amygdala (Figure 2D). Whole brain LacZ staining 
followed by sectioning and eosin red staining in four-month-old KO mice revealed that Fkpb5 was 
highly expressed in the lateral septum, which includes lateral septal nuclei dorsal (LSD), ventral (LSV) 
and intermediate (LSI) (Figure 2F); bed nucleus of the striatum terminalis (BST) (Figure 2F);  
and hippocampus (Figure 2H,J). In the four-month-old hippocampus, LacZ staining suggested that 
Fkbp5 is highly expressed in CA1, CA2, CA3 and the dentate gyrus (DG) (Figure 2D,H,J). Consistent 
with the absence of the LacZ reporter gene, WT control mice did not exhibit any LacZ staining  
(Figure 2A,C,E,G,I). 
 
Figure 2. Cont. Figure 2. Cont.
Int. J. Mol. Sci. 2016, 17, 1271 6 of 17
Int. J. Mol. Sci. 2016, 17, 1271 6 of 17 
 
 
Figure 2. FKBP5 expression in the brain of WT and KO mice. Whole brain staining using the LacZ 
reporter gene. For each pairing of photomicrographs, the left panel is the WT control sample and the 
right panel is the KO sample. Fkbp5 gene expression was observed in the brain regions of mice at one 
month (A,B) and four months (C–J) of age. Whole brain staining for LacZ in fresh tissue was 
performed (A–D) followed by hematoxylin and eosin staining in the four-month-old sample (E–J). 
Hippo (hippocampus), DR (dorsal raphe nucleus), LC (locus coeruleus), DLG (dorsal lateral 
geniculate nucleus (nu)), Rt (reticular thalamic (nu)), PH (posterior hypothalamic area), Amg 
(amygdala), Pir (piriform cortex), LSD (lateral septal nucleus, dorsal part), LSI (intermediate part), 
LSV (ventral part), BST (bed nucleus of the stria terminalis), CA (field CA of Ammon’s horn) and DG 
(dentate gyrus). Scale bars (A,B) = 2 mm, scale bars (C,D) = 1.5 mm, scale bars (E–J) = 1 mm. 
2.4. Basal Corticosterone Is Not Different Between Fkbp5−/− and WT Mice 
Multiple lines of evidence demonstrate that Fkbp5 expression responds to CORT treatment 
[32,47]. Basal CORT was measured in blood samples of KO and WT mice to determine if there was a 
genotype and sex difference. No significant differences between KO and WT were detected by 
ANOVA (genotype × sex) (interaction term: F (1,21) = 3.4, p = 0.08) (Figure 3). However, there is trend 
of lower baseline CORT in female KO compared to WT. 
i r . r ssi i t r i f i . l r i st i i si t c
t . For each pairing of ph tomicrographs, th left panel is the WT control sample and
the right panel is the KO sample. Fkbp5 gene expression was observed in the brain regions of mic
at one month (A,B) and four months (C–J) of age. Whole brain staining for LacZ in fresh ti s e
l l ( J).
(hip ocampus), DR (dorsal r phe nucleus), LC (locus coer leus), DLG (dorsal lateral geniculate
nucle s (nu)), Rt (reticular halamic (nu)), PH (posterior hy thalamic area), A g (amygdala),
Pir (piriform cortex), LSD (lateral septal nucleu , dorsal part) LSI (intermediate part), LSV (vent al
part), BST (bed nucleus of the stria terminalis), CA (field CA of mmon’s horn) and DG (dentate gyrus).
Scale bars (A,B) = 2 mm, scale bars (C,D) = 1.5 mm, scale bars (E–J) = 1 mm.
. . asal orticostero e Is ot iffere t et ee k ´/´ and WT Mice
lti l lines of evidence demonstrate that Fkbp5 expr ssion responds to CORT treatment [32,47].
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lower baseline CORT in female KO compared to WT.
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SNP FKBP5 Intron (rs1360780) FKBP5 3’-UTR (rs3800373)
Genotype Distribution HWE Genotype Distribution HWE
Ethnicity CC CT TT X2 p TT TG GG X2 p
Chinese 190 (53%) 141 (39%) 29 (8%) 0.2 0.69 192 (53%) 138 (38%) 29 (8 ) 0.4 0.55
Korean 195 (57%) 131 (38%) 17 (5%) 0.7 0.40 205 (60%) 123 (36%) 15 (4%) 0.4 0.52
Caucasian 226 (50%) 189 (42%) 34 (8%) 0.4 0.52 240 (46%) 175 (33%) 33 (6%) 0.0 0.89
Significant associations of both SNPs with alcohol measures were found in Chinese and Koreans,
but not in Caucasians (Table 2) for raw means and standard deviations and regression statistics
using transformed variables. For the rs1360780 SNP, Chinese with the CC genotype had significantly
higher scores than those with CT/TT genotypes on average quantity, binge drinking episodes, lifetime
maximum drinks and lifetime alcohol use disorder (AUD) symptoms, although lifetime maximum
drinks was only significant in Chinese men (12.0 vs. 7.2, F = 9.32, p = 0.003, R2 change = 0.049).
Koreans with the CC genotype also had significantly higher scores on AUD symptoms than Koreans
with CT/TT genotypes. For the FKBP5 3’-UTR rs3800373 SNP, Chinese with the TT genotype
had higher scores on lifetime maximum drinks and AUD symptoms than the TG/GG genotypes;
again, lifetime maximum drinks was only significant in Chinese men (11.8 vs. 7.4, F = 13.37,
p < 0.001, R2 change = 0.069). Koreans with the TT genotype also had a greater number of lifetime
AUD symptoms than Koreans with TG/GG genotypes. No gene-binge drinking interaction terms
were significant.
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Table 2. Alcohol-related variables in Chinese, Korean and Caucasian college students for two FKBP5 genotypes after co-varying for ALDH2*2 and ADH1B*2.
SNP FKBP5 Intron (rs1360780) FKBP51 UTR (rs3800373)
Genotype CC CT/TT – – – TT TG/GG – – –
Statistic M (SD) M (SD) F p Change in R2 M (SD) M (SD) F p Change in R2
Chinese n = 180 n = 160 – – – n = 183 n = 157 – – –
Quantity 3.8 (6.02) 2.9 (1.52) 2.13 0.034 0.013 3.3 (2.11) 2.9 (1.53) 1.39 0.164 0.005
Frequency 10.9 (11.31) 9.7 (9.61) 0.69 0.491 0.001 10.7 (11.30) 9.8 (9.64) 0.34 0.731 0.001
Binges 3.3 (5.20) 2.8 (4.70) 1.96 0.051 0.010 3.2 (5.17) 2.8 (4.74) 1.60 0.110 0.007
Max drinks 9.1 (8.54) 6.3 (5.21) 3.69 <0.001 0.037 8.7 (8.46) 6.4 (5.21) 2.84 0.005 0.022
AUD symptoms 1.4 (1.00) 1.2 (0.65) 2.33 0.021 0.015 1.4 (0.97) 1.2 (0.65) 1.99 0.048 0.012
Korean n = 188 n = 146 – – – n = 198 n = 136 – – –
Quantity 4.2 (2.48) 3.8 (2.21) 1.18 0.238 0.004 4.1 (2.44) 3.9 (2.20) 0.33 0.741 0.001
Frequency 15.1 (14.89) 12.2 (11.99) 1.63 0.105 0.008 14.8 (15.01) 12.5 (11.97) 0.89 0.374 0.002
Binges 6.1 (8.17) 5.2 (7.88) 1.37 0.172 0.006 5.8 (7.99) 5.4 (8.03) 0.58 0.560 0.001
Max drinks 12.1 (9.89) 10.4 (7.32) 1.57 0.118 0.007 11.7 (9.73) 10.7 (7.20) 0.52 0.603 0.000
AUD symptoms 2.1 (1.77) 1.7 (1.29) 2.40 0.017 0.017 2.0 (1.72) 1.7 (1.31) 1.95 0.052 0.011
Caucasian n = 217 n = 220 – – – n = 203 n = 235 – – –
Quantity 3.1 (1.86) 3.3 (2.24) 0.21 0.65 0.000 3.2 (1.98) 3.2 (2.20) 0.00 0.98 0.000
Frequency 24.5 (18.80) 24.2 (17.19) 0.04 0.84 0.000 24.2 (18.40) 24.1 (17.42) 0.08 0.77 0.000
Binges 8.2 (12.16) 8.0 (10.51) 0.20 0.65 0.000 8.2 (12.28) 8.0 (10.63) 0.05 0.82 0.000
Max drinks 13.9 (10.13) 14.2 (11.83) 0.23 0.63 0.001 14.0 (10.35) 13.9 (11.42) 0.06 0.81 0.000
AUD symptoms 1.0 (1.71) 1.0 (1.61) 0.10 0.76 0.000 1.0 (1.75) 1.0 (1.58) 0.63 0.43 0.001
Raw scores reported for means and standard deviations. In the analyses, alcohol variables were log transformed to adjust for right-tailed distributions. ALDH2*2 and ADH1B*2 were
covaried in all analyses, but no Caucasian possessed an ALDH2*2 allele. AUD, alcohol use disorder. Bolded p-value indicated statistically significant at p < 0.05.
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3. Discussion
The current studies investigated the role that Fkbp5 plays in alcohol drinking in both mice and
humans. Compared to WT mice, Fkbp5 KO mice exhibited increases in alcohol. These increases were
not attributed to sensitivity to a bitter-tasting solution or to differences in the rate of alcohol metabolism.
Relevant to its function in the stress response, Fkbp5 was found to be expressed in brain regions that
are important in the stress response. Consistent with a previous study [26], basal differences in CORT
levels were not observed between genotypes in male mice; although a trend toward lower basal CORT
in female Fkbp5-deficient mice can be seen in Figure 3, consistent with those findings [26]. Finally,
FKBP5 SNPs were associated with alcohol consumption in Asians, but not Caucasians. This is the first
study to demonstrate a role for the Fkbp5 gene in regulating alcohol consumption in both mouse and
human samples.
3.1. FKBP5 Is Associated with Psychiatric Disease Including Alcohol Use Disorder
Previous research has focused on FKBP5 and its association with various psychiatric
disorders [21,41,48,49]. This study demonstrated that the gene expression of Fkbp5 in the mouse
plays at least a partial role in the regulation of alcohol drinking; KO mice with no expression of Fkbp5
consumed more alcohol. Even though we do not have RNA available for FKBP5 gene expression
measurement in humans, the results from previous research also support the hypothesis that low
FKBP5 expression is associated with greater alcohol consumption. Previous research has shown that
rs1360780 (CC) homozygous subjects exhibit decreased FKBP5 mRNA expression compared to (TT)
homozygous subjects [38]. Consistent with the assumption that subjects with CC genotypes also
display lower FKBP5 mRNA expression than subjects with CT or TT genotypes, we found that Chinese
and Koreans with CC had higher scores on alcohol-related variables than CT/TT carriers.
FKBP5 SNPs and gene expression levels are associated with the onset of PTSD and anxiety disorder
in humans [20,34]. These SNPs are also associated with altered response to antidepressants [39–41].
Particularly, heterozygous and homozygous carriers of the rs3800373 (TG and GG) or rs1360780 (CT and
TT) variants are more likely to respond to antidepressant drugs [44]. A recent study also indicated that
aged (>50 years) T allele carriers of rs1360780 showed significantly higher induction of FKBP5 mRNA
expression by glucocorticoids in peripheral blood mononuclear cells [50]. Additionally, the effect of
increasing severity of childhood abuse on the resultant level of adult PTSD appears to be carried by a
subset of subjects with more common alleles of FKBP5 [34]. These findings suggest that the G allele
of rs3800373 and the T allele of rs1360780 (minor alleles) may represent protective alleles for PTSD
with a history of childhood abuse, while the major alleles, the T allele of rs3800373 and the C allele of
rs1360780, represent risk alleles. In agreement with previous studies, these major alleles are associated
with a higher risk for comorbid alcohol dependence and PTSD onset [42].
In our prior study, alcohol-dependent inpatients with the T allele of rs3800373 had more severe
withdrawal symptoms [5]. In this study, this major allele is associated with higher scores on
alcohol-related variables. Interestingly, the rs1360780 SNP is within an intronic region; a homologous
region in rodent Fkbp5 is highly conserved and has a functional hormone response element [51].
We speculate that rs1360780 may be a functional SNP that regulates gene expression, which in turn
alters alcohol drinking. In summary, the major alleles of FKBP5 SNPs are associated with higher
levels of alcohol consumption, more frequent consumption and a greater likelihood for alcohol-related
problems in this study, as well as with withdrawal symptoms in prior studies [5]. In the future,
genotyping FKBP5 SNPs in heavy drinkers and the general population may explain the previous
finding, which demonstrated that alcohol-dependent subjects had more withdrawal symptoms, higher
alcohol intake and a higher maximum number of drinks compared to the general population [52].
FKBP5 can be used as a biomarker for the diagnosis of alcohol use disorder.
This study demonstrates ethnic differences in the association of FKBP5 SNPs with alcohol-related
phenotypes. In Korean and Chinese individuals, significant associations were found between FKBP5
SNPs and alcohol drinking-related variables, but no FKBP5 gene effects were detected in Caucasian
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participants. Previous research has found a combinatorial effect of the FKBP5 gene and childhood
abuse on the risk for developing PTSD in African Americans, but not in European Americans [42].
Results of this study also indicated consistent findings across gender within each ethnicity with the
exception of the association of FKBP5 SNPs with lifetime maximum number of drinks in Chinese,
which only reached significance in the men. This lack of significance in the Chinese female sample
may be due to statistical power given the lower levels of maximum drinks in the women overall, with
the trends being similar in both genders. In addition, our analyses did not indicate that recent heavier
drinking was associated with a differential effect of the genes on lifetime heavy drinking or problems,
further indicating the consistency of the findings within each ethnic group despite differences between
the ethnic groups. Future research should continue to investigate gender and ethnic group differences
in the associations of these SNPs with alcohol-related behaviors to better understand their relationships
in those with different allele prevalence and consumption patterns, including those with more severe
alcohol-related problems.
3.2. No Basal Difference in CORT Level, but Fkbp5 Expressed in the Brain Regions Involving Stress Response
Previous studies have indicated a correlation between alcohol consumption, glucocorticoid levels
and GR activity [4,14,53]. Animal studies show that circulating levels of CORT rise after stress in Fkbp5
KO mice [54] and prenatally stressed rats [27]. Consistent with a previous study [26], we did not find
basal differences in CORT levels between genotypes in male mice; although, a trend toward lower
basal CORT in female Fkbp5-deficient mice can be seen in Figure 3. Based on our research and that of
others, it is clear that eliminating Fkbp5 does not affect basal CORT. Given the tantalizing result that
Fkbp5 is expressed in the brain regions that are relevant to stress response, it will be very interesting to
study how stress affects CORT levels in Fkbp5 KO mice.
In the periphery, as well as the CNS, Fkbp5 plays an important role in the stress response. Research
has shown Fkbp5 gene expression in the adult brain [24,55] and in mice as young as three months [56].
The current study revealed Fkbp5 expression in the brain of one-month-old mice. Brain regions with
high expression of Fkbp5 have been implicated in both the stress response and the development of
alcohol dependence [57,58]. Fkbp5 expression is induced in the brain by stress [24,27], alcohol [28,29]
and other drugs [30]. Our ongoing studies aim to understand how stress and alcohol affect Fkbp5
expression in the brain and circulating CORT levels.
The limitation of this research is that because Fkbp5 is a stress response gene, other stressors could
be confounders; for example, we did not include smoking as a covariate in our analyses and only
assessed current consumption patterns and lifetime alcohol problems in these analyses.
4. Materials and Methods
4.1. Animal and Human Subjects
All experimental protocols were reviewed and approved by the Animal Care and Use Committees
at the Indiana University School of Medicine (protocol #DS0000871R, date of approval 4/24/2013),
Purdue University (#1112000327, 10/11/2013), and the Institute of Laboratory Animal Science of
Peking Union Medical College (#ILAS-PG-2014-013). These protocols were carried out in accordance
with the NIH Guide for the Care and Use of Laboratory Animals. As described in a previous paper,
Fkbp5 knockout (Fkbp5´/´) mice were generated using the gene trapping method [46]. Fkbp5´/´ and
WT littermates were bred through heterozygous mating and were backcrossed with C57BL/6J inbred
mice for at least 5 generations.
The human study (#041122, 9/2/2004; #080978, 5/22/2008; #100399, 2/25/2010) was approved
by the University of California, San Diego (UCSD) Human Research Protections Program and had
a Certificate of Confidentiality from the USA Department of Health and Human Services. UCSD
college students of legal drinking age were recruited to participate through advertisements on campus.
All participants provided written informed consent.
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4.2. Alcohol Drinking Tests
Drinking experiments were repeated three times using different cohorts of animals, in all a total
of 82 Fkbp5´/´ (male, n = 46; female, n = 36) and 92 WT (male, n = 52; female, n = 40) mice. Fluid intake
and body weight were measured every other day throughout each experiment. The average body
weights of the mice were WT = 30 g and KO = 27 g for males and WT = 24 g and KO = 22 g for females.
At 13 weeks of age, mice were habituated to drinking in their home cages for 6 days with two 25-mL
graduated cylinders containing water. Following the habituation phase, mice were given 24-h access to
water and alcohol (EtOH). The concentration of EtOH (v/v) was increased every four days as follows:
3%, 6%, 9%, 12% and 15%. Average alcohol consumption per day was calculated and corrected for
individual differences in body weight (BW) (g EtOH/kg BW/day). Alcohol preference ratios were
then calculated (EtOH/total fluid). To exclude the possibility that KO and WT mice differed in taste
reactivity, animals were tested for quinine (0.5 µM) intake as published [59].
4.3. Alcohol Elimination Rate
At 12 weeks of age, the EtOH elimination rate was determined using a separate cohort of
Fkbp5´/´ and WT mice (4 male and 4 female mice of each genotype). An EtOH dose of 2.0 g/kg was
injected intraperitoneally (IP). Tail blood was collected at 30, 75 and 120 min after IP injection, and
plasma samples were spun down and stored at ´80 ˝C until further analysis [60]. Plasma alcohol
concentrations were measured using gas chromatography according to the instructions of the
manufacturer (HP Agilent, Santa Clara, CA, USA).
4.4. Blood Alcohol Concentration after 3-h Limited Access
Mice (10 Fkbp5´/´ and 10 WT mice of both sexes at 6 months of age) were maintained at reverse
light cycle for 3 weeks before the experiment. The subjective dark period is the active time for rodents.
In order to assess the blood EtOH levels achieved during the active period, intake volume of a 15%
EtOH solution and subsequent blood EtOH concentrations were determined after a 3-h access period,
occurring 3 h into the dark cycle. On the test day, a stacking design was used with 10-min intervals
separating the presentation of EtOH to each mouse. Beginning at 7:00 a.m., the first animal received
15% EtOH, and tail blood was taken at 10:00 a.m., with the rest of the mice following in sequence
at 10-min intervals. Blood was collected in an EDTA-coated tube and stored on ice until all samples
were collected. After collection, blood samples were centrifuged at 1500ˆ g for 10 min, and plasma
was isolated for blood alcohol concentration measurement. The same GC platform was used as
described above.
4.5. LacZ Staining
Age-matched Fkbp5´/´ (n = 6) and littermate control (n = 6) mice of both sexes were used for
morphological and histological studies. Fkbp5 gene expression in the whole brain was determined
at 1 and 4 months of age. Whole brains were collected, and the LacZ gene product, β-galactosidase
activity, was detected using X-gal [48,61]. After images were collected, the whole brain or brain slices
were fixed in 10% neutral-buffered formalin. Brains were paraffin embedded, sectioned (5 µm) and
stained with hematoxylin and eosin following standard protocols [62,63].
4.6. CORT Measurement
Basal corticosterone (CORT) levels were measured in mice. Blood samples were collected from the
submandibular vein (male: KO = 8, WT = 5; female: KO = 7, WT = 5) between 1200 and 1300 (light cycle
on at 700–1900). The concentration of CORT in the blood was determined using a competitive
enzyme immunoassay kit from Assay Designs (Ann Arbor, MI, USA), as previously published [64].
Optical densities were read on a MultiskanTM FC microplate reader (ThermoFisher Scientific Inc.,
Waltham, MA, USA). Standards and plasma samples were analyzed in duplicate. CORT concentrations
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were interpolated from standard curves generated using a four-parameter logistic curve fitting program
(GraphPad Inc., San Diego, CA, USA).
4.7. Human Sample Phenotypes
Participants were students at UCSD (n = 1162) 21–26 years of age (M = 22.0, SD = 1.34), with
an average of 15.1 years of education (SD = 0.89), who reported that all 4 of their grandparents
were entirely of Chinese (n = 360, 48% female), Korean (n = 343, 50% female) or Caucasian (n = 449,
48% female) ethnicity. Participants completed the time-line follow-back measure to evaluate alcohol
consumption for the preceding 90 days [65,66]. A standard drink was defined as 12 oz (355 mL) of
beer, 5 oz (150 mL) of wine or 1.5 oz (45 mL) of hard liquor. These amounts are the equivalent of
approximately 14 g of pure ethanol. Participants also completed the Semi-Structured Assessment for
the Genetics of Alcohol use disorder [67,68] with a trained research interviewer. During a portion
of this interview, participants recounted the maximum number of drinks ever consumed in a 24-h
period and were assessed for the 11 DSM-IV alcohol abuse and dependence symptoms (range 0–11;
American Psychological Association, 1994) [69]. Five alcohol-related variables were calculated from
these assessments: (1) average quantity of drinking during the previous three months (standard
drinks/occasion); (2) average frequency of drinking during the previous three months (days/month);
(3) number of binge drinking episodes (four or more drinks on an occasion for women and five or
more on an occasion for men) during the previous three months; (4) lifetime maximum number of
alcohol drinks ever consumed in a 24-h period; and (5) number of lifetime alcohol use disorder (AUD)
symptoms (alcohol abuse and dependence). Lifetime non-drinkers (defined as never having had a
standard drink of alcohol) were excluded (n = 30).
4.8. Human Sample Genotyping
Blood samples were collected by fingertip puncture and delivered to the Genomics and
Bioinformatics Core of Indiana Alcohol Research Center for genotyping. Genomic DNA was
isolated by the “HotSHOT” method [70], and TaqMan probes were used for allelic discrimination
(Life Technologies, Foster City, CA, USA). Genotyping procedures were reported previously [71].
Two SNPs, rs1360780 (major/minor allele, C/T) within intron 2 and rs3800373 (T/G) in the 3’UTR,
were selected for genotyping. The two SNPs selected comprise one single large linkage disequilibrium
(LD) block based on previous LD structure analysis [38].
4.9. Statistical Analysis
Total fluid intake and alcohol consumption and preference differences at tested EtOH
concentrations between genotypes were assessed via 2-way repeated measures analysis of variance
(ANOVA) with Sidak’s test for multiple comparisons. Differences in quinine intake and CORT data
were analyzed using Student’s t-test.
In humans, data were analyzed using linear regressions. All alcohol variables were log
transformed to account for the non-normality of the distribution of raw scores. Based on the genotypic
distributions (Table 1) and consistent with prior studies [44], we dichotomized the genotype groups,
such that CT and TT were combined for the FKBP5 intron SNP (rs1360780) and TG and GG were
combined for the FKBP5 3’-UTR SNP (rs3800373). Because of the strong association of alcohol
metabolizing genes (e.g., ALDH2, ADH1B) with alcohol-related behaviors [72], we co-varied for
these two genotypes (dichotomized variables for those with and without the variant ALDH2*2 and
ADH1B*2 alleles) by entering them in linear regressions as the first step prior to entering the FKBP5
gene in the second step. Note that the ALDH2*2 allele was present only in the Chinese and Korean
groups, whereas the ADH1B*2 was present in all three ethnic groups.
We tested for gender differences in the relationship of the FKBP5 SNPs with alcohol-related
behaviors by including gene-gender interaction terms in the regression models. For any interaction
term with a p < 0.10, we then examined the relationship of the gene with the alcohol-related variable
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in each gender separately. We used a similar approach to examine the possibility that current heavy
alcohol consumption might differentially affect the association of the genes with lifetime heavy
drinking and AUD symptoms; in these analyses, we included interaction terms of the genes with
having binged in the past 3 months.
5. Conclusions
Despite these limitations, our study demonstrates that FKBP5 is associated with alcohol
consumption phenotypes in mice and in humans of Asian, but not Caucasian, descent. The current
study has established the foundation for future studies investigating the potential role of FKBP5 in
responses to acute and chronic drinking, alcohol withdrawal symptoms and the interplay of stress
and Fkbp5 expression on the development of alcohol dependence. FKBP5 may well be an interesting
therapeutic target for the prevention and treatment of stress-related alcohol drinking behavior.
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